DIA
HAE icon

Davidson Investment Advisors’s Haemonetics HAE Stock Holding History

Davidson Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-142,585
Closed -$4.99M – 202
2016
Q1 		$4.99M Buy
142,585
+14,660
+11% +$473K 0.84% 60
2015
Q4 		$4.12M Sell
127,925
-9,025
-7% -$293K 0.69% 58
2015
Q3 		$4.42M Buy
+136,950
New +$5.15M 0.8% 52

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Davidson Investment Advisors's HAE Position: Q2 2016 in Review

Davidson Investment Advisors sold out of Haemonetics (HAE) in Q2 2016, closing a stake of 142,585 shares — an estimated $4.99M sold.

Davidson Investment Advisors first reported a position in HAE in Q3 2015 and held it in 3 quarters. The position peaked at $4.99M in Q1 2016. 178 funds tracked by Wall St. Rank hold HAE as of Q2 2016.

  • Davidson Investment Advisors reported no remaining Haemonetics position as of Q2 2016 after selling out during the quarter.
  • Davidson Investment Advisors sold 142,585 Haemonetics shares in Q2 2016, an estimated $4.99M.
  • Davidson Investment Advisors first reported a position in Haemonetics in Q3 2015 and held it in 3 quarters.
  • Davidson Investment Advisors's Haemonetics position peaked at $4.99M in Q1 2016.
  • 178 funds tracked by Wall St. Rank held Haemonetics as of Q2 2016.

Based on Davidson Investment Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.